NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Brightseed

Brightseed

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.brightseedbio.com/

Last Round

Grant

Dec 19, 2023

Est. Valuation

$300M

Total Funding Raised

$146.8M

Company Overview

Brightseed is a biotechnology company that provides an AI-powered innovation platform for health and life sciences companies to discover, validate, and commercialize natural bioactive compounds.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, ML Platforms, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Data as a Service, Services & Consulting

AI Layer

Application

Keywords

bioactive discoveryAI ingredient discoveryForager AIfunctional ingredientsgut healthfood as medicinemetabolic healthnutraceuticalsdiscovery platformfood techbiotech platformsmall molecule discoveryclinical validationdata-as-a-serviceDaaSGLP-1 companionupcycled ingredients

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Brightseed Comparables

Compare Brightseed with similar companies based on industry and business-model similarity.

Brightseed comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nuritas
83%
One Bio
79%
The Live Green Co
78%

Brightseed Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 19, 2023
Series BMay 9, 2022
GrantJul 1, 2021
Series A ExtensionSep 15, 2020
Series AJun 11, 2020

Key People

Founding team and executive leadership

Lee Chae

Co-founder And CEO

Founding Team

Brightseed Investors

Notable investors and investment history

Brightseed investors
InvestorRounds
Horizons VenturesSeries A Extension, Seed, Series A
Conti VenturesSeed
Germin8 VenturesSeed, Series A, Series B, Series A Extension
Lewis & Clark PartnersSeries B, Series A Extension
The Bill & Melinda Gates Foundation TrustGrant
S2G InvestmentsSeed, Series A, Series B, Series A Extension
AgFunderSeries B, Series A Extension, Seed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 25, 2026

    Launched an Innovation Platform for plant bioactives and health benefits.

  • May 22, 2025

    Launched Bio Gut Core to improve gut barrier function.

Brightseed Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Brightseed Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Brightseed's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range37
Year Founded2018
Last FundingDec 19, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.